Signaling of transforming growth factor-β family members through Smad proteins

European Journal of Biochemistry

Volumn 267, Issue 24, 2000, Pages 6954-6967

  Itoh, Susumu ^a   Itoh, Fumiko ^a   Goumans, Marie José ^a   Dijke, Peter Ten ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Serine threonine kinase; Signal transduction; Smad; Transcription; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

AUTOPHOSPHORYLATION; CANCER INHIBITION; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENE TARGETING; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

DNA-BINDING PROTEINS; GENE TARGETING; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; UBIQUITINS;

EID: 0034533657     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01828.x     Document Type: Short Survey

References (171)

1. The transforming growth factor-βs
2. Controlling TGF-β signaling
3. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice
4. Nodal signalling in vertebrate development
5. Role of transforming growth factor β in human disease
6. The role of TGF-β signaling in cancer
7. TGF-β receptor signaling
8. TGF-β signal transduction
9. Identification of human activin and TGF β type I receptors that form heteromeric kinase complexes with type II receptors
10. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type 1 receptors
11. Characterization of type 1 receptors for transforming growth factor-β and activin
12. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
13. Activin receptor-like kinase 1 modulates transforming growth factor-β signaling in the regulation of angiogenesis
14. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1
15. Smads as transcriptional co-modulators
16. Transcriptional control by the TGF-β/Smad signaling system
17. Nomenclature: Vertebrate mediators of TGFβ family signals
18. Smads: Transcriptional activators of TGF-β responses
19. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-@b intracellular signaling specificity
20. Determinants of specificity in TGF-β signal transduction
21. The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation
22. Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors
23. Xenopus Smad4β is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes
24. Spemann organizer activity of Smad10
25. Identification of two Smad4 proteins in Xenopus. Their common and distinct properties
26. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
27. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
28. Smad6 inhibits signalling by the TGF-β superfamily
29. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
30. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium
31. Smad7 Is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells
32. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors
33. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells
34. Roles of pathway-specific and inhibitory Smads in activin receptor signaling
35. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein
36. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
37. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer
38. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signaling
39. Human Smad3 and Smad4 are sequence-specific transcription activators
40. A short amino acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3
41. Alternatively-spliced variant of Smad2 lacking exon 3: Comparison with wild-type Smad2 and Smad3
42. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
43. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4
44. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors
45. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor
46. Structural basis of Smad2 recognition by the Smad anchor for receptor activation
47. Microtubule binding to Smads may regulate TGFβ activity
48. Regulation of Smad activity
49. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors
50. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
51. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling
52. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase
53. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling
54. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes
55. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation
56. Importin β mediates nuclear translocation of Smad 3
57. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFβ-dependent phosphorylation
58. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal
59. Transforming growth factor β1 induces nuclear export of inhibitory Smad7
60. Identification of STRAP, a novel WD domain protein in transforming growth factor-β signaling
61. STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling
62. Smad6 as a transcriptional corepressor
63. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6
64. Roles of autocrine, TGF-β and receptor and Smad signaling in adipocyte differentiation
65. Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells
66. Smad6 functions as an intracellular antagonist of some TGF-β family members during Xenopus embryogenesis
67. Smad7 differentially regulates transforming growth factor β-mediated signaling pathways
68. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members
69. Induction of Smad6 mRNA by bone morphogenetic proteins
70. Signal transduction. Feedback from inhibitory SMADs
71. Regulation of Smad7 promoter by direct association with Smad3 and Smad4
72. Efficient, TGF-b induction of the Smad7 gene requires co-operation between, AP-1 Sp1 and Smad proteins on the mouse Smad7 promoter
73. Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter
74. Smad6 is a Smad1/5-induced Smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter
75. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling
76. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β
77. Interaction of Smad complexes with tripartite DNA-binding sites
78. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
79. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic
80. Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter
81. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor-β induced Smad-dependent transcriptional activation
82. Interaction and functional cooperation of, NF-κB, with Smads: Transcriptional regulation of the JunB promoter
83. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor β
84. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-β
85. Interaction of Smad3 with a proximal smad-binding element of the human alpha2 (I) procollagen gene promoter required for transcriptional activation by TGF-β
86. Interaction and functional cooperation of PEBP2/CBF with Smads, synergistic induction of the immunoglobulin germline Cα promoter
87. Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes
88. Transcriptional regulation of the transforming growth factor-β-inducible mouse germ line Igα constant region gene by functional cooperation of Smad, CREB, and AML family members
89. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-β involves transactivation by Smads
90. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2
91. Characterization of a bone morphogenetic protein-responsive Smad-binding element
92. A human Mad protein acting as a BMP-regulated transcriptional activator
93. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation
94. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
95. Role of p300, a transcriptional coactivator, in signalling of TGF-β
96. Physical and functional interaction of SMADs and p300/CBP
97. TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein
98. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor β transcriptional responses in endothelial cells
99. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300
100. Activation of Smad1-mediated transcription by p300/CBP
101. Transcriptional activating activity of Smad4: Roles of SMAD hetero-oligomerization and enhancement by an associating transactivator
102. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain
103. The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors
104. A Smad transcriptional corepressor
105. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads
106. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling
107. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein
108. Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling
109. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling
110. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor
111. A novel Smad nuclear interacting protein (SNIP1) suppresses p300-dependent TGF-β signal transduction
112. A transcriptional partner for MAD proteins in TGF-β signalling
113. Smad4 and FAST-1 in the assembly of activin-responsive factor
114. Smad3 and Smad4 cooperate with c-June/c-Fos to mediate TGF-β-induced transcription
115. Smads bind directly to the June family of AP-1 transcription factors
116. Smad3/Smad4 and AP-1 complexes synergize in transcriptional activation of the c-June promoter by transforming growth factor-β
117. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members
118. TGF-β upregulates the β5 integrin subunit expression via Sp1 and Smad signaling
119. Role of Smad proteins and transcription factor Sp1 in p21WAF-{super1}/Cip-{super1} regulation by transforming growth factor-β
120. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
121. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins
122. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways
123. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1
124. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-β antiproliferative responses in colon cancer cells
125. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras
126. The role of the Smad3 protein in phorbol ester-induced promoter expression
127. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ
128. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ /STAT pathway
129. A mechanism of suppression of TGF-β/SMAD signaling by NF-kappa B/RelA
130. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer
131. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways
132. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation
133. Ubiquitin-dependent degradation of TGF-β -activated Smad2
134. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
135. DPC4 gene in various tumor types
136. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells
137. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
138. Frequency of Smad gene mutations in human cancers
139. Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion
140. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
141. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor β signaling by targeting Smads to the ubiquitin-proteasome pathway
142. Smad3 mutant mice develop metastatic colorectal cancer
143. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
144. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
145. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
146. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo
147. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo
148. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2
149. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
150. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis
151. Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development
152. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
153. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
154. Smad5 is essential for left-right asymmetry in mice
155. Targeted disruption of Smad3 reveals an essential role in transforming growth factor-β mediated signal transduction
156. Targeted disruption of Smad3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β
157. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
158. A role for Smad6 in development and homeostasis of the cardiovascular system
159. Transforming growth factor β1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor
160. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-June N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling
161. TGF-β induces fibronectin synthesis through a c-June N-terminal kinase-dependent, Smad4-independent pathway
162. ATF-2 Is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling
163. Smad proteins physically interact with calmodulin
164. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling
165. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes
166. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression
167. Carboxy-terminally truncated Gli3 proteins associate with Smads
168. Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3
169. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
170. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif
171. Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor μE3, and Smad proteins